Janus Henderson Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $839K | Hold |
60,028
| – | – | ﹤0.01% | 1697 |
|
|
2025
Q1 | $888K | Hold |
60,028
| – | – | ﹤0.01% | 1673 |
|
|
2024
Q4 | $1.22M | Buy |
60,028
+7,900
| +15% | +$161K | ﹤0.01% | 1585 |
|
|
2024
Q3 | $1.52M | Hold |
52,128
| – | – | ﹤0.01% | 1448 |
|
|
2024
Q2 | $1.21M | Sell |
52,128
-590
| -1% | -$13.7K | ﹤0.01% | 1522 |
|
|
2024
Q1 | $1.08M | Buy |
52,718
+26
| +0% | +$533 | ﹤0.01% | 1603 |
|
|
2023
Q4 | $1.13M | Sell |
52,692
-75
| -0.1% | -$1.61K | ﹤0.01% | 1558 |
|
|
2023
Q3 | $1.09M | Buy |
52,767
+13
| +0% | +$268 | ﹤0.01% | 1518 |
|
|
2023
Q2 | $1.55M | Buy |
52,754
+10,586
| +25% | +$312K | ﹤0.01% | 1369 |
|
|
2023
Q1 | $972K | Buy |
42,168
+26,279
| +165% | +$606K | ﹤0.01% | 1648 |
|
|
2022
Q4 | $442K | Sell |
15,889
-15,891
| -50% | -$442K | ﹤0.01% | 1772 |
|
|
2022
Q3 | $976K | Buy |
31,780
+15,712
| +98% | +$483K | ﹤0.01% | 1657 |
|
|
2022
Q2 | $472K | Sell |
16,068
-67,627
| -81% | -$1.99M | ﹤0.01% | 1804 |
|
|
2022
Q1 | $2.69M | Sell |
83,695
-16,768
| -17% | -$539K | ﹤0.01% | 1148 |
|
|
2021
Q4 | $4.48M | Buy |
100,463
+92,593
| +1,177% | +$4.13M | ﹤0.01% | 1091 |
|
|
2021
Q3 | $397K | Buy |
+7,870
| New | +$397K | ﹤0.01% | 1729 |
|
|
2018
Q1 | – | Sell |
-28,125
| Closed | -$440K | – | 1367 |
|
|
2017
Q4 | $440K | Buy |
+28,125
| New | +$440K | ﹤0.01% | 1234 |
|